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low-, moderate-, and high-score groups, with corresponding probabilities of ureteral stone. We evaluate the STONE
score in a multi-institutional cohort compared with physician gestalt and hypothesize that it has a sufﬁciently high
speciﬁcity to allow clinicians to defer computed tomography (CT) scan in patients with suspected nephrolithiasis.
Methods: We assessed the STONE score with data from a randomized trial for participants with suspected nephrolithiasis
who enrolled at 9 emergency departments between October 2011 and February 2013. In accordance with STONE
predictors, we categorized participants into low-, moderate-, or high-score groups. We determined the performance of the
STONE score and physician gestalt for ureteral stone.
Results: Eight hundred forty-ﬁve participants were included for analysis; 331 (39%) had a ureteral stone. The global
performance of the STONE score was superior to physician gestalt (area under the receiver operating characteristic
curve¼0.78 [95% conﬁdence interval {CI} 0.74 to 0.81] versus 0.68 [95% CI 0.64 to 0.71]). The prevalence of ureteral stone
on CTscan ranged from14% (95%CI 9% to 19%) to 73% (95%CI 67% to 78%) in the low-, moderate-, and high-score groups.
The sensitivity and speciﬁcity of a high score were 53% (95% CI 48% to 59%) and 87% (95% CI 84% to 90%), respectively.
Conclusion: The STONE score can successfully aggregate patients into low-, medium-, and high-risk groups and predicts
ureteral stone with a higher speciﬁcity than physician gestalt. However, in its present form, the STONE score lacks
sufﬁcient accuracy to allow clinicians to defer CT scan for suspected ureteral stone. [Ann Emerg Med. 2016;67:423-432.]
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INTRODUCTION
Background
Pain from a kidney stone is a common reason for
US emergency department (ED) visits, accounting for
more than 1 million visits annually.1-3 Although most
patients are discharged after an evaluation and symptomatic
treatment, approximately 10% require inpatient admission.1,4,5
Individuals who are unable to pass their stone may continue to
experience pain, vomiting, and urinary symptoms, and
ultimately require a urologic intervention.6The STONEscore is
a recently derived clinical prediction rule designed to aid
clinicians to evaluate the risk of ureteral stone and important
alternative diagnoses for patientswith suspectednephrolithiasis.67, no. 4 : April 2016The STONE score is calculated as a weighted sum of 5
categorical predictors; the points for each predictor are based on
the estimated coefﬁcients froma regressionmodel constructed to
predict the presence of a ureteral stone. Patients were classiﬁed
into low-,moderate-, and high-score groups with corresponding
outcomeprobabilities of ureteral stone and important alternative
diagnoses. Patients with a high score had an 89% probability of
ureteral stone and a 1.6% probability of alternative diagnosis;
those with a low STONE score had a 9% probability of ureteral
stone (the probability of alternative diagnosiswas not reported in
this group). In accordance with these outcome probabilities, the
authors concluded that patientswith a high STONEscore could
potentially receive ultrasonography, reduced-dose computed
tomography (CT), or no further imaging.However, the authors
didnot report the sensitivity and speciﬁcityof theSTONEscore,Annals of Emergency Medicine 423
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What is already known on this topic
The STONE score is a clinical decision rule to risk-
stratify urolithiasis.
What question this study addressed
Can the STONE score be used to rule in stones such
that computed tomography (CT) scanning is
unnecessary?
What this study adds to our knowledge
In this validation study of 845 adults receiving CT
scanning for suspected urolithiasis, using a high-risk
score rather than CT to rule in urolithiasis identiﬁed
53% of stones while falsely suggesting stones in 13%
of patients without calculi. Furthermore, one of the
score’s 5 core elements failed to predict urolithiasis.
How this is relevant to clinical practice
This independent assessment found the STONE
score to be an inaccurate tool to defer CT scanning
and identiﬁed one of its core elements as invalid.which are important test characteristics of the decision
rule, as opposed to the positive predictive value, which is
heavily inﬂuenced by the prevalence of the outcome in the
original study population.7,8 A clinical decision rule that
seeks to rule in ureteral stone should have an excellent
speciﬁcity.6-11
Importance
Abdominal CT has become the most frequently used
imaging test for suspected kidney stone because of its
perceived superior diagnostic accuracy and ability to identify
important alternative diagnoses, such as appendicitis and
diverticulitis.4,12-17 Despite a signiﬁcant increase in the use
of CT scans for patients with suspected kidney stone,
there has been no demonstrable improvement in patient
outcomes.18-20 A recent national survey described a 10-fold
increase in CT use during 1996 to 2007 for suspected
kidney stone, without associated increases in kidney stone
diagnoses, important alternative diagnoses, or hospitalization
of kidney stone patients.20 Furthermore, abdominal CT
entails radiation exposure with attendant cancer risk, is
associated with increased ED length of stay, and contributes
to increasing annual care cost for acute nephrolithiasis,
estimated in excess of $5 billion.21-25 If the STONE score
is found to identify patients with ureteral stone with
sufﬁcient accuracy without relying on further imaging, it424 Annals of Emergency Medicinecould signiﬁcantly improve the evaluation of patients with
suspected nephrolithiasis.7,9,26,27
Goals of This Investigation
We sought to determine whether the STONE score
could be used to safely decrease CT scan use in patients
with suspected nephrolithiasis. Using data from a recently
completed multicenter randomized trial comparing CT
scan to ultrasonography for patients with suspected
nephrolithiasis, we determined the discrimination,
calibration, and test characteristics of the STONE score to
predict ureteral stone. In addition, we compared the test
characteristics of the STONE score to those of
unstructured physician gestalt. We hypothesized that a high
STONE score (10 to 13) would have sufﬁcient speciﬁcity
to diagnose ureteral stone and allow clinicians to defer CT
scan in patients with suspected nephrolithiasis.MATERIALS AND METHODS
Study Design and Setting
To evaluate the STONE score, we conducted a
secondary analysis using data from a recently conducted
randomized comparative effectiveness trial, the Study of
Ultrasonography Versus Computed Tomography for
Suspected Nephrolithiasis.19 The randomized trial was
conducted at 15 academic EDs across the United States
between October 2011 and February 2013. Details of the
participating EDs have been reported.28 Brieﬂy, the
participating sites were academic EDs with emergency
medicine residencies and emergency ultrasonography
fellowships across the United States, with representation from
a number of settings: urban, rural, university based, and safety
net hospitals. The sites varied by size, annual census, and
patient population served. This randomized trial was
performedwith institutional review board approval at each site
and informed consent was obtained from all participants. This
current study was performed with institutional review board
approval at the University of California, San Francisco.
Selection of Participants
Adult participants with suspected kidney stones that
required imaging (determined by an attending emergency
physician) were randomly assigned to receive point-of-care
ultrasonography, radiology ultrasonography, or CT as their
initial imaging test. Patients were excluded from enrollment if
they were pregnant, at high risk of an important alternative
(non–kidney stone) diagnosis, had received a kidney
transplant, required dialysis, had a known solitary kidney, or
weighed more than 129 kg if men or 113 kg if women. The
STONE score consists of 5 demographic and clinical variablesVolume 67, no. 4 : April 2016
Figure 1. Patient ﬂow diagram.
Wang et al External Validation of the STONE Scorecollected during the ED visit: sex, race, nausea or vomiting,
duration of pain symptoms, and hematuria on urine dipstick
test. To closely model the validation study with the inclusion
and outcome criteria of the original report, we restricted the
analysis to sites that used urine dipstick testing for hematuria
and to participantswhounderwent aCT scanduring the index
ED visit. Of the 2,759 total patients analyzed in the
randomized trial, 845 participants had the data available for
validation of the STONE score (Figure 1).
Methods of Measurement
Research coordinators used a standardized data collection
form to collect detailed demographic, clinical, laboratory,
and imaging data during the index ED visit. Before patient
enrollment, research coordinators attended a 2-day meeting
to receive training in study protocol, ﬁlling out forms,
and data collection techniques. Additional weekly online
meetings provided more training about data collection.
Patients were directly interviewed for the subjective variablesVolume 67, no. 4 : April 2016during the index ED visits. These data were recorded on
paper forms and faxed to a data coordinating center, which
provided immediate feedback for form completeness.
Research coordinators were blinded to the study hypothesis.
Dual assessments were not performed.
To calculate a STONE score for each participant in the
validation cohort, we determined the presence of each of the
5 STONE score predictors (sex, timing [duration of time
since symptom onset in hours], race [black versus nonblack],
nausea/vomiting, and hematuria). Points were assigned
when the predictor was present (male sex, 2 points; duration
of pain<6 hours, 3 points; duration of pain 6 to 24 hours, 1
point; nonblack race, 3 points; nausea alone, 1 point;
vomiting, 2 points; hematuria on urine dipstick testing, 3
points) after the initial report. The points received from
individual predictors were summed to form a STONE score.
Treating physicians (either resident or attending) were
asked to estimate the likelihood of kidney stone as the cause
of the participants’ symptoms. The physician could selectAnnals of Emergency Medicine 425
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50%, 51% to 75%, and 76% to 100%. This question was
asked before randomization and receipt of any imaging, and
the physicians were blinded to the outcome of the study.
Outcome Measures
Ureteral stone was deﬁned as the visualization of a
kidney stone in the ureter (including stones at the
ureteropelvic junction, ureter, and ureterovesicular
junction) on CT. Important alternative diagnosis (such
as pyelonephritis, malignancy, diverticulitis, pancreatitis,
appendicitis, cholecystitis, pulmonary disorders, small
bowel obstruction, and ovarian torsion) were deﬁned with
the same system of classiﬁcation as used in the original
study.29 The presence of ureteral stone and alternative
diagnosis was recorded during the index ED visit by trained
research coordinators according to dictated CT reports.
To assess the reproducibility of the ureteral stone and
important alternative diagnosis outcomes for this study,
detailed CT result dictations for each participant were
obtained from 2 of the 9 sites (sites 6 and 8, including data
from 103 participants, 12% of the validation cohort) and
reviewed by one of the study authors (R.C.W.), who
abstracted whether a ureteral stone or important alternative
diagnosis was present and compared this with the data
abstracted by the study coordinators in a blinded fashion.
The interobserver k agreement between study author
(R.C.W.) and research coordinators for the ureteral stone
outcome was 1.0 (perfect agreement) and 0.79 for
important alternative diagnoses (good agreement).
Primary Data Analysis
One hundred twelve subjects (12%) had missing data
for 1 or more variables (dipstick hematuria [n¼85],
duration of pain [n¼9], race [n¼9], nausea/vomiting
[n¼3], and ureteral stone [n¼8]). We chose to focus our
analysis of missing data on the urine dipstick variable. An
analysis was performed to explore how results varied when
values for the missing urine dipstick values were imputed.
Missing values in the urine dipstick variable were replaced
with imputed values. These imputed data were used in a
multivariate logistic regression model, and the strength
and direction of the associations between the STONE
variables and ureteral stone were similar to those of the
base model (Table E1, available online at http://www.
annemergmed.com). Thus, we believe that it is acceptable
to analyze data for participants with complete data.
We applied the STONE score to the validation
cohort (n¼845). Multivariate logistic regression was ﬁrst
performed to calculate odds ratios to determine the
associations between the STONE score predictors with426 Annals of Emergency Medicineureteral stone, specifying that the standard errors allow
intrasite correlation. To examine the lack of association
between the nonblack predictor and ureteral stone, we
estimated the odds ratios of the STONE score predictors
for ureteral stone in nonblack and black participants
separately. The discrimination and calibration of the
STONE score and physician gestalt were calculated with
the area under the receiver operating characteristic curve
(AUC) and Hosmer-Lemeshow goodness-of-ﬁt test.
A score was calculated for each participant according to the
observed predictor values. Participants were then categorized
into low- (0 to 5),moderate- (6 to 9), andhigh-score (10 to 13)
groups, and the prevalence of ureteral stones and important
alternative diagnoses were determined for each group. The test
characteristics of the STONE score were calculated,
considering the high-score group (10 to 13points) as a positive
test result and ureteral stone on CT as a positive outcome.
Similarly, the prevalence of ureteral stones and important
alternative diagnoses were determined for each physician
gestalt group. The test characteristics of physician gestalt were
calculated, considering the 76% to100% likelihood group as a
positive test result and ureteral stone on CT as a positive
outcome. An additional analysis was performed to assess
whether the STONE score could be improved by omitting
race (black versus nonblack). The AUC and test characteristics
were calculated for this modiﬁed STONE score.
The uncertainty of the AUC and test characteristic
estimates was summarized with exact binomial 95%
conﬁdence intervals (CIs). The interobserver reliability of
the ureteral stone outcome measurement was determined
with Cohen’s k. Stata (version 13; StataCorp, College
Station, TX) was used to perform the statistical analysis.RESULTS
Characteristics of Study Subjects
Of the 1,627 subjects who received CT scan in the
randomized trial, 957 were enrolled at an ED that used
urine dipstick testing. Of the 957, 112 were missing data
(85 were missing urine dipstick) (Figure 1). The remaining
845 were included in the ﬁnal analysis (mean age 40 years
[range 18 to 75 years], 49% female patients, and 43%
white) (Table 1). The percentage of participants with a
ureteral stone on CT was 39%, whereas the proportion of
participants who had a signiﬁcant alternative diagnosis was
5.3%. Eleven percent of participants required admission to
an inpatient service from the ED.Main Results
In the validation cohort, the overall direction of the
associations between the STONE predictors and ureteralVolume 67, no. 4 : April 2016
Table 2. Prevalence of ureteral stone and important alternative
diagnoses compared with physician gestalt in this validation
cohort and in the original validation study.
Table 1. Baseline characteristics of participants in this validation
cohort versus the original validation study.6
Characteristics
This Validation
Cohort (n[845),
Frequency (%)
Original Validation
Study* (n[491),
Frequency (%)
Age (SD), y 40 (13) 46 (15)
Male sex 413 (49) 273 (56)
Race
White 359 (43) 411 (84)
Black 169 (20) 57 (12)
Hispanic 235 (28) †
Asian 45 (5) †
Mixed 27 (3) All other
Native American Indian 8 (1) 23 (5)
Paciﬁc Islander 2 (0.2) †
Radiology ﬁndings
Ureteral stone 331 (39.2) 274 (56)
Alternative diagnosis 45 (5.3) 18 (3.7)
Disposition
Admission to hospital 95 (11) 52 (11)
*Data from the original study describe the internal validation cohort.6
†Data from the initial study are not available.
Wang et al External Validation of the STONE Scorestone were similar to that of the original study, but the
strength of the associations was attenuated; nonblack
race was not signiﬁcantly associated with ureteral stone
(Table E1, available online at http://www.annemergmed.
com). In nonblack participants, each of the STONE
predictors was signiﬁcantly associated with ureteral stone,
but the duration of symptoms was not (Table E2, available
online at http://www.annemergmed.com). The
distribution of the duration of symptoms differedFigure 2. Receiver operating characteristic curves of the
STONE score and physician gestalt. Numbers indicate the
STONE score and physician gestalt cutoffs.
Volume 67, no. 4 : April 2016signiﬁcantly in nonblack and black participants: 57% of
nonblack participant presented with less than 24 hours of
pain compared with 42% of black participants (P¼.002).
Figure 2 graphically represents the receiver operating
characteristic curves of the STONE score (as a numeric
score 0 to 13) and physician gestalt (categorized into 0%
to 5%, 6% to 25%, 26% to 50%, 51% to 75%, and 76%
to 100% likelihood of ureteral stone). On inspection,
the STONE score receiver operating characteristic curve
appears to be closer to the left upper corner compared with
that of physician gestalt. The main difference in the curves
is the portion closest to the origin, suggesting that the
STONE score speciﬁcity is superior to that of physician
gestalt, whereas sensitivity is not much different. The AUC
of the STONE score was 0.78 (95% CI 0.74 to 0.81)
compared with that of physician gestalt, 0.68 (95% CI
0.64 to 0.71). It has been suggested that AUCs of 0.7 to
0.8 could be considered acceptable and those of 0.8 to 0.9
excellent.30 The Hosmer-Lemeshow goodness-of-ﬁt test
of the STONE score resulted in a value of 8.5 (P¼.40),
indicating acceptable ﬁt. Calibration of the STONE score
was represented graphically by plotting observed versus
predicted outcomes (Figure E1, available online at http://
www.annemergmed.com).Risk Score
Frequency
(% of Cohort)
Prevalence (%) [95% CI]
Ureteral
Stone
Alternate
Diagnosis
STONE score in this validation cohort
High 242/845 (28.6) 176/242 (72.7)
[66.7–78.2]
3/242 (1.2)
[0.3–3.6]
Moderate 395/845 (46.7) 127/395 (32.2)
[27.6–37.0]
30/395 (7.6)
[5.2–10.7]
Low 208/845 (24.6) 28/208 (13.5)
[9.1–18.9]
12/208 (5.8)
[3.0–10.0]
Physician gestalt in this validation cohort, %
76–100 356/809 (44.0) 194/356 (54.5)
[49.2–59.8]
10/356 (2.8)
[1.4–5.1]
51–75 199/809 (24.6) 74/199 (37.2)
[30.5–44.3]
9/199 (4.5)
[2.1–8.4]
26–50 136/809 (16.8) 26/136 (19.1)
[12.9–26.7]
12/136 (8.8)
[4.6–14.9]
0–25 118/809 (14.6) 20/118 (17.0)
[10.7–25.0]
9/118 (7.6)
[3.5–14.0]
STONE score in the original validation study
High 185/491 (37.7) 164/185 (88.6)
[83.1–92.8]
1.6
Moderate 230/491 (46.8) 118/230 (51.3)
[44.6–57.9]
*
Low 76/491 (15.5) 7/76 (9.2)
[3.8–18.0]
*
*Information not available.
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Figure 3. Prevalence of ureteral stone and important alternative diagnoses by STONE score versus original validation study.6 Error
bars represent 95% CIs.
External Validation of the STONE Score Wang et alTable 2 displays the prevalence of ureteral stone and
alternative diagnoses in the groups with low, moderate,
and high STONE score and the physician gestalt groups.
The prevalence of ureteral stone ranged from 13.5% in
the low-score group to 72.7% in the high-score group.
The CIs of the estimates of prevalence do not overlap,
indicating that the prevalence of ureteral stone was
signiﬁcantly different between the groups. The prevalence
of important alternative diagnoses was 1.2% in the high-
score group, but the upper limit of the 95% CI wasTable 3. Test characteristics of the STONE score and physician gesta
Risk Score Sensitivity, % (95% CI) Speciﬁci
STONE score (10–13) 53 (48–59) 87
STONE score (11–13) 37 (32–42) 92
STONE score (5–13) 96 (93–98) 23
Gestalt (76%–100%) 62 (56–67) 67
Gestalt (50%–100%) 85 (81–89) 42
428 Annals of Emergency Medicine3.6%. The prevalence of ureteral stone and important
alternative diagnosis in this cohort compared with that in
the original validation study is graphically represented in
Figure 3.
The prevalence of ureteral stone increased as the
physician gestalt rating increased from 0% to 25%, to 76%
to 100%. There was some overlap in the CIs of the
estimates of ureteral stone prevalence, and the ranges of
prevalence were more narrow when physician gestalt was
used to categorize participants. Similar patterns werelt for ureteral stone.
ty, % (95% CI) DLR, % (95% CI) –LR, % (95% CI)
(84–90) 4.1 (3.2–5.3) 0.5 (0.5–0.6)
(89–94) 4.6 (3.3–6.3) 0.7 (0.6–0.7)
(19–27) 1.2 (1.2–1.3) 0.2 (0.1–0.3)
(63–71) 1.9 (1.6–2.2) 0.6 (0.5–0.7)
(38–47) 1.5 (1.4–1.6) 0.3 (0.3–0.4)
Volume 67, no. 4 : April 2016
Wang et al External Validation of the STONE Scoreobserved for the prevalence of important alternative
diagnoses.
The test characteristics of the STONE score are
displayed in Table 3. The authors of the original study
suggested that patients with a high score (a STONE score
of 10 to 13) could receive ultrasonography, reduced-dose
CT scan, or, in some cases, no further imaging. Thus, we
chose to report the test characteristics of the STONE score,
considering a score of 10 to 13 as a positive test result.
The sensitivity and speciﬁcity were 53% (95% CI 48%
to 59%) and 87% (95% CI 84% to 90%), respectively.
The STONE score positive likelihood ratio was 4.1, and
negative likelihood ratio was 0.5. By considering a score of
11 to 13 as a positive test result, the speciﬁcity increased
but the sensitivity decreased, and fewer participants would
be considered as having a positive result. Conversely, by
considering a STONE score of 5 to 13 as a positive test
result, the sensitivity increased, but the speciﬁcity was
drastically reduced.
The sensitivity and speciﬁcity of physician gestalt
(considering a rating of 76% to 100% as a positive test
result) were 62% (95% CI 56% to 67%) and 67% (95%
CI 63% to 71%), respectively. At this 76% to 100%
cutoff, the gestalt sensitivity is superior to the high STONE
score, but with overlapping 95% CIs. The STONE score
speciﬁcity is superior to physician gestalt at either cutoff.
We explored whether the STONE score could be
improved by omitting the nonblack variable because it
was not associated with ureteral stone in our cohort. The
modiﬁed “STNE” score would then include sex, duration
of symptoms, nausea or vomiting, and hematuria, and the
score would range from 0 to 10 points. A comparison of
the receiver operating characteristic curves can be found in
Table E3 and Figure E2, available online at http://www.
annemergmed.com. The AUC of the STONE score and
the modiﬁed score were both 0.78, with overlapping 95%
CIs. When deﬁning a positive test result as a modiﬁed
score of 8 to 10, the sensitivity and speciﬁcity were 42%
(95% CI 37% to 48%) and 90% (87% to 92%),
respectively, similar to the STONE score test
characteristics.
LIMITATIONS
There are some limitations of this study. This was a
secondary analysis of a randomized trial and thus is
vulnerable to some methodological ﬂaws. We did not
validate the STONE score in all patients with suspected
ureteral stone, but instead in patients who an attending
emergency physician deemed should undergo CT scan
imaging. This group likely represents those patients for
whom attending emergency physicians have greaterVolume 67, no. 4 : April 2016uncertainty about the diagnosis of kidney stone or
alternative diagnosis compared with those who did not
receive imaging. For example, patients deemed at very low
risk or at very high risk for kidney stone (ie, classic renal
colic in a patient with a history of kidney stones and
hematuria) may have been less likely to be included. Also,
to assemble a cohort with the available data for the STONE
predictors and outcome, we restricted the study to subjects
who received CT scan at sites that performed urine dipstick
testing, which may have resulted in selection bias. Although
this is a limitation of the present study, we believe that
there is still value in assessing the STONE score in this
population who required CT testing. Physicians’ threshold
for ordering CT scans for suspected kidney stone has
decreased over time: emergency physician use of CT scan
has increased 10-fold during the last 15 years, without a
signiﬁcant change in the diagnosis of kidney stone or rates
of admission for kidney stone.5 The patients for whom
there is greater diagnostic uncertainty should be the focus
of a decision rule that functions to increase diagnostic
certainty.
Another limitation is the lack of an assessment of
the reliability of the predictor variables. Although we
collected data prospectively in the randomized trial, dual
assessments were not performed. Although sex, race,
and hematuria on urine dipstick test are likely to have
high interrater reliability, the presence of nausea or
vomiting and the hours since the symptoms began require
prospective evaluation. Finally, we sought to address
potential measurement bias of the outcome and found that
at 2 of the 9 sites, the interobserver agreement of the
measurement of the ureteral stone outcome was perfect.
We have no reason to believe that measurement bias would
exist at the other 7 sites.
DISCUSSION
Using data from a large, randomized, comparative
effectiveness trial, we evaluated the performance of the
STONE score, a clinical decision rule derived to predict the
presence of ureteral stone on CT scan. We compared the
performance of the STONE score with that of physician
gestalt, using several metrics of test performance, including
discrimination, calibration, risk stratiﬁcation, and test
characteristics such as sensitivity, speciﬁcity, and likelihood
ratios. The STONE score successfully categorizes
patients into low-, moderate-, and high-risk groups, with
corresponding probabilities of ureteral stone ranging from
13% to greater than 70%. The authors of the original study
suggested that the STONE score could potentially be used
to defer CT because patients with a high STONE score
would be considered to have a ureteral stone and managedAnnals of Emergency Medicine 429
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ureteral stone without need for further testing would
require an excellent speciﬁcity and positive likelihood ratio.
We found that the STONE score appears to have superior
speciﬁcity compared with physician gestalt. However, a
high STONE score was found to have a poor sensitivity
(53%) and a moderate speciﬁcity (87%). In accordance
with these ﬁndings, we believe that the STONE score does
not have a sufﬁciently high speciﬁcity to defer CT scan
without additional imaging.
We attempted to reﬁne the STONE score to improve
prediction, using the data from this validation cohort. We
ﬁrst explored the effect of changing the deﬁnition of a
positive test result to a score of 11 to 13, which increased the
speciﬁcity (92%; 95% CI 89% to 94%) and positive
likelihood ratio, but worsened the sensitivity and negative
likelihood ratio and decreased the proportion of patients
identiﬁed with ureteral stone. We also considered
modifying the STONE score to identify patients at very low
risk for kidney stone, which would require an excellent
sensitivity and negative likelihood ratio to defer CT. When
the cutoff for a positive test result was decreased to a
STONE score of 5, the sensitivity was improved but
speciﬁcity was greatly reduced. The main problem with this
approach is the presence of important alternative diagnoses
in patients with suspected kidney stone. As in the original
study, we found that the probability of ureteral stone
was inversely related to the probability of an important
alternative diagnosis. Thus, a low STONE score would not
exclude important alternative diagnoses, which would likely
be unacceptable to clinicians. Finally, we found that race
(black versus nonblack) was not statistically associated with
ureteral stone, perhaps because of the difference in the
pattern of the duration of symptoms between the nonblack
and black participants. According to our sensitivity analysis,
we did not ﬁnd a signiﬁcant difference in performance
between the STONE score, including race and a modiﬁed
score that omitted race. This suggests that the race
predictor could be discarded in future studies of the
STONE score. Ultimately, we could not improve the
STONE score sufﬁciently to develop a decision rule that
could provide a clear course of action with the available data.
There are some differences between the present study
and the internal validation of the STONE score conducted
by the authors of the original study. Our external validation
cohort was larger and included participants from multiple
institutions; it included a larger proportion of women and
black participants. This is relevant to the STONE score
because nonblack race and male sex are predictors in the
score. Compared with the original internal validation, the
STONE score performed with slightly lower discrimination430 Annals of Emergency Medicine(0.78 versus 0.82) in our cohort. Also, the prevalence
of ureteral stone in the high-score group (ie, positive
predictive value) in the original validation was 89%, and
in this study it was 73%. This likely reﬂects the tendency
of decision rules to perform less well in external cohorts
compared with the population in which it was derived.
Also, positive predictive values are known to vary with
disease prevalence, and the overall prevalence was greater
in the original study (56% versus 39%).8
Clinical decision rules that provide accurate outcome
probabilities may be acceptable in clinical practice.8
However, this type of rule does not clearly recommend a
decision, and it is assumed that accurate predictions will
improve clinical decisionmaking. Few decision rules of this
type have undergone formal impact analysis, and clinicians
do not know whether their use will actually improve
patient outcomes compared with usual care. The Wells
criteria were initially developed as a clinical decision
rule that grouped patients into low, moderate, and
high probabilities for pulmonary embolism. However,
pulmonary embolism was not excluded in the low-risk
group, and it was not clear how clinicians should interpret a
low versus moderate score.10 The Wells criteria were later
combined with D-dimer testing to recommend a clear
course of action, which allows clinicians to avoid CT
imaging.31 Similarly, more studies would be needed to
combine the STONE score with additional testing (such as
ultrasonography) to allow clinicians to defer CT imaging.
In summary, the STONE score successfully aggregated
patients into low-, moderate-, and high-risk groups for
ureteral stone. Also, it was superior to physician gestalt for
predicting ureteral stone. However, the speciﬁcity of a high
STONE score was modest and likely not sufﬁcient to
provide a clear course of action. These observations suggest
that further development of the STONE score is needed
to produce a successful decision rule that would allow
clinicians to defer CT scan.7,10,32 Alternatively, a new
decision instrument could be derived and validated to
improve the evaluation of ureteral stone by allowing
clinicians to defer CT imaging.
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Figure E1. Calibration plot of the STONE score: observed
versus predicted risk of ureteral stone.
Table E1. Strength of association between STONE score variables
and ureteral stone in the validation cohort, imputed cohort, and
original validation study.
Factor
Validation Cohort,
OR (95% CI),
N[845
Imputed Cohort,
OR (95% CI),
N[929
Original
Study, OR
(95% CI)
Sex
Female Reference Reference Reference
Male 3.4 (2.3–4.8) 3.3 (2.4–4.6) 4.3 (3.1–6.0)
Timing (duration
of pain to
presentation), h
>24 Reference Reference Reference
6–24 1.6 (1.2–2.1) 1.6 (1.2–2.0) 1.9 (1.3–2.7)
<6 3.1 (1.7–4.8) 2.7 (1.5–5.1) 6.3 (4.3–9.3)
Origin (race)
Black Reference Reference Reference
Nonblack 1.4 (0.9–2.2) 1.4 (0.9–2.2) 6.8 (3.8–12.6)
Nausea and
vomiting
None Reference Reference Reference
Nausea alone 1.2 (0.8–1.7) 1.3 (0.9–1.9) 2.0 (1.4–2.9)
Vomiting 2.9 (1.8–4.8) 2.8 (1.8–4.5) 5.3 (3.5–7.9)
Hematuria on
urine dipstick
Absent Reference Reference Reference
Present 3.6 (1.9–6.8) 3.7 (2.0–6.7) 5.6 (4.0–8.0)
Wang et al External Validation of the STONE ScoreTable E2. Strength of association between STONE score variables
and ureteral stone in the black versus nonblack participants.
Factor
Validation
Cohort,
OR (95% CI),
N[845
Black
Participants,
OR (95% CI),
N[169
Nonblack,
OR (95% CI),
N[676
Sex
Female Reference Reference Reference
Male 3.4 (2.3–4.8) 2.7 (1.1–6.9) 3.6 (2.2–5.6)
Timing (duration
of pain to
presentation), h
>24 Reference Reference Reference
6–24 1.6 (1.2–2.1) 1.4 (1.0–1.8) 1.6 (1.1–2.2)
<6 3.1 (1.7–4.8) 1.6 (0.6–4.3) 3.5 (1.9–6.5)
Origin (race)
Black Reference NA NA
Nonblack 1.4 (0.9–2.2)
Nausea and
vomiting
None Reference Reference Reference
Nausea alone 1.2 (0.8–1.7) 1.4 (0.5–4.1) 1.1 (0.7–1.9)
Vomiting 2.9 (1.8–4.8) 4.9 (1.6–14.6) 2.6 (1.4–4.6)
Hematuria on
urine dipstick
Absent Reference Reference Reference
Present 3.6 (1.9–6.8) 2.1 (0.9–4.6) 4.2 (2.2–7.8)
Volume 67, no. 4 : April 2016Figure E2. Receiver operating characteristic curve of STONE
score versus modiﬁed STONE score.
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Table E3. Test characteristics of the modiﬁed STONE score for ureteral stone.
Sensitivity, % (95% CI) Speciﬁcity, % (95% CI) DLR, % (95% CI) –LR, % (95% CI)
Modiﬁed score (7–10) 58 (52–63) 84 (82–87) 3.7 (3.0–4.6) 0.5 (0.4–0.6)
Modiﬁed score (8–10) 42 (37–48) 90 (87–92) 4.1 (3.1–5.4) 0.6 (0.6–0.7)
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